sitemap.xml - Search
About 83,900 results
Open links in new tab
    Kizdar net | Kizdar net | Кыздар Нет
  1. Cytogenetics in the management of multiple Myeloma: The guidelines …

    Oct 1, 2023 · Here, we provide an overview of recurrent cytogenetic aberrations that can be detected in MM patient and we propose …

  2. Alterations in chromosome 1q in multiple myeloma randomized clinical ...

    Jan 25, 2024 · This systematic review assesses the current reporting trends of +1q, the efficacy of existing regimens on +1q, and its …

  3. Overview of 1q abnormalities in multiple myeloma: scientific opinions ...

    Multiple myeloma (MM) is a haematological malignancy characterised by high genomic heterogeneity. One of the most common …

  4. The role of 1q abnormalities in multiple myeloma: Genomic insights ...

    Feb 1, 2025 · In this review, we discuss the underlying mechanisms of 1q abnormalities in driving disease risk, prognostic …

    Missing:
    • PMF
    Must include:
  5. Chromosome 1q alterations in transplant-eligible multiple ... - Frontiers

    Aug 17, 2026 · Chromosome 1q abnormalities are among the most frequent cytogenetic alterations in multiple myeloma (MM), yet …

  6. Prognostic Impact of Chromosome 1q Gain/Amplification in Multiple ...

    Gain/amplification of chromosome arm 1q (+1q) is among the most frequent cytogenetic abnormalities (CAs) in multiple myeloma …

    Missing:
    • PMF
    Must include:
  7. Outcomes of patients with multiple myeloma and 1q gain ... - Nature

    Jan 10, 2024 · The prognostic impact of additional copies of chromosome 1q (1q + ) on outcomes of newly-diagnosed multiple …

  8. Prognostic Impact of Chromosome 1q Gain/Amplification in Multiple ...

    Apr 19, 2026 · Gain/amplification of chromosome arm 1q (+1q) is among the most frequent cytogenetic abnormalities (CAs) in …

    Missing:
    • PMF
    Must include:
  9. (PDF) Overview of 1q abnormalities in multiple myeloma: scientific ...

    Feb 13, 2025 · Multiple myeloma (MM) is a haematological malignancy characterised by high genomic heterogeneity. One of the …

  10. Patients with 1q abnormalities were more likely to present with additional high-risk cytogenetic abnormalities. The median overall …

    Missing:
    • PMF
    Must include: